Innovex Medical Files for IPO in Hong Kong to Boost Product Development
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
Ascentage Pharma Gains CDE Approval for Phase I Study of APG-5918
Suzhou-based Ascentage Pharma (HKG: 6855) has announced that it has received approval from the Center...
China Releases 14th Five-Year Plan for National Health Informatization
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
Zai Lab Reports 33% YOY Revenue Growth in Q3 2022
Chinese biopharmaceutical firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) released its Q3 2022 earnings...
GSK Partners with CASPC to Advance HIV Sustained Care Advocacy in China
The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline...
3SBio Receives NMPA Review for Pediatric ITP Thrombopoietin Filing
China-based 3SBio Inc. (HKG: 1530) has announced that the National Medical Products Administration (NMPA) has...
Boston Scientific Partners with Omron for Atrial Fibrillation Management
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at...
Takeda Partners with AWS and Accenture to Launch Innovation Incubator at CIIE
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda...
Betta Pharmaceuticals’ BPI-D0316 Shows Promise in Phase II/III Lung Cancer Study
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced the summary report of a Phase...
BeiGene Reports 88% YOY Revenue Growth in Q3 2022
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) released its Q3 2022 earnings...
Shandong Xinhua and Bayer Announce Strategic Partnership at CIIE
A strategic partnership between China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) and Bayer Consumer...
Medtronic Partners with Shanghai JiaHui Hospital at CIIE
US-based Medtronic Inc. (NYSE: MDT) has announced a partnership with Shanghai JiaHui International Hospital, unveiled...
ChainGen Bio Raises RMB 45M in Angel Round for X-oligo Conjugates Development
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...
Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes,...
Haisco’s HSK16149 Accepted for Review by NMPA for Diabetic Neuropathic Pain
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that a market approval filing...
Cowell Health Partners with AstraZeneca to Enhance Cancer Care at CIIE
Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th...
Liaoning Chengda’s ACYW135 Meningococcal Vaccine Receives NMPA Clearance
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) has announced that it has received clinical...
Zhaoke Ophthalmology Enrolls First Patients for ZKY001 in Phase II Trials
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
CDE Seeks Public Feedback on New Drug Benefit-Risk Assessment Guidelines
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...